Recombinant Human M-CSF Protein - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

TABLE OF CONTENTS

1 Market Overview

• 1.1 Recombinant Human M-CSF Protein Product Introduction
• 1.2 Global Recombinant Human M-CSF Protein Market Size Forecast (2020-2031)
• 1.3 Recombinant Human M-CSF Protein Market Trends & Drivers
  • 1.3.1 Recombinant Human M-CSF Protein Industry Trends
  • 1.3.2 Recombinant Human M-CSF Protein Market Drivers & Opportunity
  • 1.3.3 Recombinant Human M-CSF Protein Market Challenges
  • 1.3.4 Recombinant Human M-CSF Protein Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global Recombinant Human M-CSF Protein Players Revenue Ranking (2024)
• 2.2 Global Recombinant Human M-CSF Protein Revenue by Company (2020-2025)
• 2.3 Key Companies Recombinant Human M-CSF Protein Manufacturing Base Distribution and Headquarters
• 2.4 Key Companies Recombinant Human M-CSF Protein Product Offered
• 2.5 Key Companies Time to Begin Mass Production of Recombinant Human M-CSF Protein
• 2.6 Recombinant Human M-CSF Protein Market Competitive Analysis
  • 2.6.1 Recombinant Human M-CSF Protein Market Concentration Rate (2020-2025)
  • 2.6.2 Global 5 and 10 Largest Companies by Recombinant Human M-CSF Protein Revenue in 2024
  • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human M-CSF Protein as of 2024)
• 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 Purity>95%
  • 3.1.2 Purity<=95%
• 3.2 Global Recombinant Human M-CSF Protein Sales Value by Type
  • 3.2.1 Global Recombinant Human M-CSF Protein Sales Value by Type (2020 VS 2024 VS 2031)
  • 3.2.2 Global Recombinant Human M-CSF Protein Sales Value, by Type (2020-2031)
  • 3.2.3 Global Recombinant Human M-CSF Protein Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 Medical and Biological Laboratories
  • 4.1.2 University Laboratories
  • 4.1.3 Others
• 4.2 Global Recombinant Human M-CSF Protein Sales Value by Application
  • 4.2.1 Global Recombinant Human M-CSF Protein Sales Value by Application (2020 VS 2024 VS 2031)
  • 4.2.2 Global Recombinant Human M-CSF Protein Sales Value, by Application (2020-2031)
  • 4.2.3 Global Recombinant Human M-CSF Protein Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

• 5.1 Global Recombinant Human M-CSF Protein Sales Value by Region
  • 5.1.1 Global Recombinant Human M-CSF Protein Sales Value by Region: 2020 VS 2024 VS 2031
  • 5.1.2 Global Recombinant Human M-CSF Protein Sales Value by Region (2020-2025)
  • 5.1.3 Global Recombinant Human M-CSF Protein Sales Value by Region (2026-2031)
  • 5.1.4 Global Recombinant Human M-CSF Protein Sales Value by Region (%), (2020-2031)
• 5.2 North America
  • 5.2.1 North America Recombinant Human M-CSF Protein Sales Value, 2020-2031
  • 5.2.2 North America Recombinant Human M-CSF Protein Sales Value by Country (%), 2024 VS 2031
• 5.3 Europe
  • 5.3.1 Europe Recombinant Human M-CSF Protein Sales Value, 2020-2031
  • 5.3.2 Europe Recombinant Human M-CSF Protein Sales Value by Country (%), 2024 VS 2031
• 5.4 Asia Pacific
  • 5.4.1 Asia Pacific Recombinant Human M-CSF Protein Sales Value, 2020-2031
  • 5.4.2 Asia Pacific Recombinant Human M-CSF Protein Sales Value by Region (%), 2024 VS 2031
• 5.5 South America
  • 5.5.1 South America Recombinant Human M-CSF Protein Sales Value, 2020-2031
  • 5.5.2 South America Recombinant Human M-CSF Protein Sales Value by Country (%), 2024 VS 2031
• 5.6 Middle East & Africa
  • 5.6.1 Middle East & Africa Recombinant Human M-CSF Protein Sales Value, 2020-2031
  • 5.6.2 Middle East & Africa Recombinant Human M-CSF Protein Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions Recombinant Human M-CSF Protein Sales Value Growth Trends, 2020 VS 2024 VS 2031
• 6.2 Key Countries/Regions Recombinant Human M-CSF Protein Sales Value, 2020-2031
• 6.3 United States
  • 6.3.1 United States Recombinant Human M-CSF Protein Sales Value, 2020-2031
  • 6.3.2 United States Recombinant Human M-CSF Protein Sales Value by Type (%), 2024 VS 2031
  • 6.3.3 United States Recombinant Human M-CSF Protein Sales Value by Application, 2024 VS 2031
• 6.4 Europe
  • 6.4.1 Europe Recombinant Human M-CSF Protein Sales Value, 2020-2031
  • 6.4.2 Europe Recombinant Human M-CSF Protein Sales Value by Type (%), 2024 VS 2031
  • 6.4.3 Europe Recombinant Human M-CSF Protein Sales Value by Application, 2024 VS 2031
• 6.5 China
  • 6.5.1 China Recombinant Human M-CSF Protein Sales Value, 2020-2031
  • 6.5.2 China Recombinant Human M-CSF Protein Sales Value by Type (%), 2024 VS 2031
  • 6.5.3 China Recombinant Human M-CSF Protein Sales Value by Application, 2024 VS 2031
• 6.6 Japan
  • 6.6.1 Japan Recombinant Human M-CSF Protein Sales Value, 2020-2031
  • 6.6.2 Japan Recombinant Human M-CSF Protein Sales Value by Type (%), 2024 VS 2031
  • 6.6.3 Japan Recombinant Human M-CSF Protein Sales Value by Application, 2024 VS 2031
• 6.7 South Korea
  • 6.7.1 South Korea Recombinant Human M-CSF Protein Sales Value, 2020-2031
  • 6.7.2 South Korea Recombinant Human M-CSF Protein Sales Value by Type (%), 2024 VS 2031
  • 6.7.3 South Korea Recombinant Human M-CSF Protein Sales Value by Application, 2024 VS 2031
• 6.8 Southeast Asia
  • 6.8.1 Southeast Asia Recombinant Human M-CSF Protein Sales Value, 2020-2031
  • 6.8.2 Southeast Asia Recombinant Human M-CSF Protein Sales Value by Type (%), 2024 VS 2031
  • 6.8.3 Southeast Asia Recombinant Human M-CSF Protein Sales Value by Application, 2024 VS 2031
• 6.9 India
  • 6.9.1 India Recombinant Human M-CSF Protein Sales Value, 2020-2031
  • 6.9.2 India Recombinant Human M-CSF Protein Sales Value by Type (%), 2024 VS 2031
  • 6.9.3 India Recombinant Human M-CSF Protein Sales Value by Application, 2024 VS 2031

7 Company Profiles

• 7.1 Novartis
  • 7.1.1 Novartis Profile
  • 7.1.2 Novartis Main Business
  • 7.1.3 Novartis Recombinant Human M-CSF Protein Products, Services and Solutions
  • 7.1.4 Novartis Recombinant Human M-CSF Protein Revenue (US$ Million) & (2020-2025)
  • 7.1.5 Novartis Recent Developments
• 7.2 Amgen
  • 7.2.1 Amgen Profile
  • 7.2.2 Amgen Main Business
  • 7.2.3 Amgen Recombinant Human M-CSF Protein Products, Services and Solutions
  • 7.2.4 Amgen Recombinant Human M-CSF Protein Revenue (US$ Million) & (2020-2025)
  • 7.2.5 Amgen Recent Developments
• 7.3 Betta Pharmaceuticals
  • 7.3.1 Betta Pharmaceuticals Profile
  • 7.3.2 Betta Pharmaceuticals Main Business
  • 7.3.3 Betta Pharmaceuticals Recombinant Human M-CSF Protein Products, Services and Solutions
  • 7.3.4 Betta Pharmaceuticals Recombinant Human M-CSF Protein Revenue (US$ Million) & (2020-2025)
  • 7.3.5 Betta Pharmaceuticals Recent Developments
• 7.4 Thermo Fisher Scientific Inc.
  • 7.4.1 Thermo Fisher Scientific Inc. Profile
  • 7.4.2 Thermo Fisher Scientific Inc. Main Business
  • 7.4.3 Thermo Fisher Scientific Inc. Recombinant Human M-CSF Protein Products, Services and Solutions
  • 7.4.4 Thermo Fisher Scientific Inc. Recombinant Human M-CSF Protein Revenue (US$ Million) & (2020-2025)
  • 7.4.5 Thermo Fisher Scientific Inc. Recent Developments
• 7.5 Eli Lilly and Company
  • 7.5.1 Eli Lilly and Company Profile
  • 7.5.2 Eli Lilly and Company Main Business
  • 7.5.3 Eli Lilly and Company Recombinant Human M-CSF Protein Products, Services and Solutions
  • 7.5.4 Eli Lilly and Company Recombinant Human M-CSF Protein Revenue (US$ Million) & (2020-2025)
  • 7.5.5 Eli Lilly and Company Recent Developments
• 7.6 Bio-Techne
  • 7.6.1 Bio-Techne Profile
  • 7.6.2 Bio-Techne Main Business
  • 7.6.3 Bio-Techne Recombinant Human M-CSF Protein Products, Services and Solutions
  • 7.6.4 Bio-Techne Recombinant Human M-CSF Protein Revenue (US$ Million) & (2020-2025)
  • 7.6.5 Bio-Techne Recent Developments
• 7.7 Merck
  • 7.7.1 Merck Profile
  • 7.7.2 Merck Main Business
  • 7.7.3 Merck Recombinant Human M-CSF Protein Products, Services and Solutions
  • 7.7.4 Merck Recombinant Human M-CSF Protein Revenue (US$ Million) & (2020-2025)
  • 7.7.5 Merck Recent Developments
• 7.8 Yeasen
  • 7.8.1 Yeasen Profile
  • 7.8.2 Yeasen Main Business
  • 7.8.3 Yeasen Recombinant Human M-CSF Protein Products, Services and Solutions
  • 7.8.4 Yeasen Recombinant Human M-CSF Protein Revenue (US$ Million) & (2020-2025)
  • 7.8.5 Yeasen Recent Developments
• 7.9 Sino Biological
  • 7.9.1 Sino Biological Profile
  • 7.9.2 Sino Biological Main Business
  • 7.9.3 Sino Biological Recombinant Human M-CSF Protein Products, Services and Solutions
  • 7.9.4 Sino Biological Recombinant Human M-CSF Protein Revenue (US$ Million) & (2020-2025)
  • 7.9.5 Sino Biological Recent Developments
• 7.10 Miltenyi Biotec
  • 7.10.1 Miltenyi Biotec Profile
  • 7.10.2 Miltenyi Biotec Main Business
  • 7.10.3 Miltenyi Biotec Recombinant Human M-CSF Protein Products, Services and Solutions
  • 7.10.4 Miltenyi Biotec Recombinant Human M-CSF Protein Revenue (US$ Million) & (2020-2025)
  • 7.10.5 Miltenyi Biotec Recent Developments
• 7.11 Proteintech
  • 7.11.1 Proteintech Profile
  • 7.11.2 Proteintech Main Business
  • 7.11.3 Proteintech Recombinant Human M-CSF Protein Products, Services and Solutions
  • 7.11.4 Proteintech Recombinant Human M-CSF Protein Revenue (US$ Million) & (2020-2025)
  • 7.11.5 Proteintech Recent Developments
• 7.12 BioLegend
  • 7.12.1 BioLegend Profile
  • 7.12.2 BioLegend Main Business
  • 7.12.3 BioLegend Recombinant Human M-CSF Protein Products, Services and Solutions
  • 7.12.4 BioLegend Recombinant Human M-CSF Protein Revenue (US$ Million) & (2020-2025)
  • 7.12.5 BioLegend Recent Developments

8 Industry Chain Analysis

• 8.1 Recombinant Human M-CSF Protein Industrial Chain
• 8.2 Recombinant Human M-CSF Protein Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Cost Structure
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Sales Model and Sales Channels
  • 8.5.1 Recombinant Human M-CSF Protein Sales Model
  • 8.5.2 Sales Channel
  • 8.5.3 Recombinant Human M-CSF Protein Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
    • 10.1.1.1 Research Programs/Design
    • 10.1.1.2 Market Size Estimation
    • 10.1.1.3 Market Breakdown and Data Triangulation
  • 10.1.2 Data Source
    • 10.1.2.1 Secondary Sources
    • 10.1.2.2 Primary Sources
• 10.2 Author Details
• 10.3 Disclaimer

List of Tables

Table 1. Recombinant Human M-CSF Protein Market Trends

Table 2. Recombinant Human M-CSF Protein Market Drivers & Opportunity

Table 3. Recombinant Human M-CSF Protein Market Challenges

Table 4. Recombinant Human M-CSF Protein Market Restraints

Table 5. Global Recombinant Human M-CSF Protein Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global Recombinant Human M-CSF Protein Revenue Market Share by Company (2020-2025)

Table 7. Key Companies Recombinant Human M-CSF Protein Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Recombinant Human M-CSF Protein Product Type

Table 9. Key Companies Time to Begin Mass Production of Recombinant Human M-CSF Protein

Table 10. Global Recombinant Human M-CSF Protein Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human M-CSF Protein as of 2024)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Recombinant Human M-CSF Protein Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 14. Global Recombinant Human M-CSF Protein Sales Value by Type (2020-2025) & (US$ Million)

Table 15. Global Recombinant Human M-CSF Protein Sales Value by Type (2026-2031) & (US$ Million)

Table 16. Global Recombinant Human M-CSF Protein Sales Market Share in Value by Type (2020-2025)

Table 17. Global Recombinant Human M-CSF Protein Sales Market Share in Value by Type (2026-2031)

Table 18. Global Recombinant Human M-CSF Protein Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 19. Global Recombinant Human M-CSF Protein Sales Value by Application (2020-2025) & (US$ Million)

Table 20. Global Recombinant Human M-CSF Protein Sales Value by Application (2026-2031) & (US$ Million)

Table 21. Global Recombinant Human M-CSF Protein Sales Market Share in Value by Application (2020-2025)

Table 22. Global Recombinant Human M-CSF Protein Sales Market Share in Value by Application (2026-2031)

Table 23. Global Recombinant Human M-CSF Protein Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 24. Global Recombinant Human M-CSF Protein Sales Value by Region (2020-2025) & (US$ Million)

Table 25. Global Recombinant Human M-CSF Protein Sales Value by Region (2026-2031) & (US$ Million)

Table 26. Global Recombinant Human M-CSF Protein Sales Value by Region (2020-2025) & (%)

Table 27. Global Recombinant Human M-CSF Protein Sales Value by Region (2026-2031) & (%)

Table 28. Key Countries/Regions Recombinant Human M-CSF Protein Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 29. Key Countries/Regions Recombinant Human M-CSF Protein Sales Value, (2020-2025) & (US$ Million)

Table 30. Key Countries/Regions Recombinant Human M-CSF Protein Sales Value, (2026-2031) & (US$ Million)

Table 31. Novartis Basic Information List

Table 32. Novartis Description and Business Overview

Table 33. Novartis Recombinant Human M-CSF Protein Products, Services and Solutions

Table 34. Revenue (US$ Million) in Recombinant Human M-CSF Protein Business of Novartis (2020-2025)

Table 35. Novartis Recent Developments

Table 36. Amgen Basic Information List

Table 37. Amgen Description and Business Overview

Table 38. Amgen Recombinant Human M-CSF Protein Products, Services and Solutions

Table 39. Revenue (US$ Million) in Recombinant Human M-CSF Protein Business of Amgen (2020-2025)

Table 40. Amgen Recent Developments

Table 41. Betta Pharmaceuticals Basic Information List

Table 42. Betta Pharmaceuticals Description and Business Overview

Table 43. Betta Pharmaceuticals Recombinant Human M-CSF Protein Products, Services and Solutions

Table 44. Revenue (US$ Million) in Recombinant Human M-CSF Protein Business of Betta Pharmaceuticals (2020-2025)

Table 45. Betta Pharmaceuticals Recent Developments

Table 46. Thermo Fisher Scientific Inc. Basic Information List

Table 47. Thermo Fisher Scientific Inc. Description and Business Overview

Table 48. Thermo Fisher Scientific Inc. Recombinant Human M-CSF Protein Products, Services and Solutions

Table 49. Revenue (US$ Million) in Recombinant Human M-CSF Protein Business of Thermo Fisher Scientific Inc. (2020-2025)

Table 50. Thermo Fisher Scientific Inc. Recent Developments

Table 51. Eli Lilly and Company Basic Information List

Table 52. Eli Lilly and Company Description and Business Overview

Table 53. Eli Lilly and Company Recombinant Human M-CSF Protein Products, Services and Solutions

Table 54. Revenue (US$ Million) in Recombinant Human M-CSF Protein Business of Eli Lilly and Company (2020-2025)

Table 55. Eli Lilly and Company Recent Developments

Table 56. Bio-Techne Basic Information List

Table 57. Bio-Techne Description and Business Overview

Table 58. Bio-Techne Recombinant Human M-CSF Protein Products, Services and Solutions

Table 59. Revenue (US$ Million) in Recombinant Human M-CSF Protein Business of Bio-Techne (2020-2025)

Table 60. Bio-Techne Recent Developments

Table 61. Merck Basic Information List

Table 62. Merck Description and Business Overview

Table 63. Merck Recombinant Human M-CSF Protein Products, Services and Solutions

Table 64. Revenue (US$ Million) in Recombinant Human M-CSF Protein Business of Merck (2020-2025)

Table 65. Merck Recent Developments

Table 66. Yeasen Basic Information List

Table 67. Yeasen Description and Business Overview

Table 68. Yeasen Recombinant Human M-CSF Protein Products, Services and Solutions

Table 69. Revenue (US$ Million) in Recombinant Human M-CSF Protein Business of Yeasen (2020-2025)

Table 70. Yeasen Recent Developments

Table 71. Sino Biological Basic Information List

Table 72. Sino Biological Description and Business Overview

Table 73. Sino Biological Recombinant Human M-CSF Protein Products, Services and Solutions

Table 74. Revenue (US$ Million) in Recombinant Human M-CSF Protein Business of Sino Biological (2020-2025)

Table 75. Sino Biological Recent Developments

Table 76. Miltenyi Biotec Basic Information List

Table 77. Miltenyi Biotec Description and Business Overview

Table 78. Miltenyi Biotec Recombinant Human M-CSF Protein Products, Services and Solutions

Table 79. Revenue (US$ Million) in Recombinant Human M-CSF Protein Business of Miltenyi Biotec (2020-2025)

Table 80. Miltenyi Biotec Recent Developments

Table 81. Proteintech Basic Information List

Table 82. Proteintech Description and Business Overview

Table 83. Proteintech Recombinant Human M-CSF Protein Products, Services and Solutions

Table 84. Revenue (US$ Million) in Recombinant Human M-CSF Protein Business of Proteintech (2020-2025)

Table 85. Proteintech Recent Developments

Table 86. BioLegend Basic Information List

Table 87. BioLegend Description and Business Overview

Table 88. BioLegend Recombinant Human M-CSF Protein Products, Services and Solutions

Table 89. Revenue (US$ Million) in Recombinant Human M-CSF Protein Business of BioLegend (2020-2025)

Table 90. BioLegend Recent Developments

Table 91. Key Raw Materials Lists

Table 92. Raw Materials Key Suppliers Lists

Table 93. Recombinant Human M-CSF Protein Downstream Customers

Table 94. Recombinant Human M-CSF Protein Distributors List

Table 95. Research Programs/Design for This Report

Table 96. Key Data Information from Secondary Sources

Table 97. Key Data Information from Primary Sources

List of Figures

Figure 1. Recombinant Human M-CSF Protein Product Picture

Figure 2. Global Recombinant Human M-CSF Protein Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Recombinant Human M-CSF Protein Sales Value (2020-2031) & (US$ Million)

Figure 4. Recombinant Human M-CSF Protein Report Years Considered

Figure 5. Global Recombinant Human M-CSF Protein Players Revenue Ranking (2024) & (US$ Million)

Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Recombinant Human M-CSF Protein Revenue in 2024

Figure 7. Recombinant Human M-CSF Protein Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 8. Purity>95% Picture

Figure 9. Purity<=95% Picture

Figure 10. Global Recombinant Human M-CSF Protein Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 11. Global Recombinant Human M-CSF Protein Sales Value Market Share by Type, 2024 & 2031

Figure 12. Product Picture of Medical and Biological Laboratories

Figure 13. Product Picture of University Laboratories

Figure 14. Product Picture of Others

Figure 15. Global Recombinant Human M-CSF Protein Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 16. Global Recombinant Human M-CSF Protein Sales Value Market Share by Application, 2024 & 2031

Figure 17. North America Recombinant Human M-CSF Protein Sales Value (2020-2031) & (US$ Million)

Figure 18. North America Recombinant Human M-CSF Protein Sales Value by Country (%), 2024 VS 2031

Figure 19. Europe Recombinant Human M-CSF Protein Sales Value, (2020-2031) & (US$ Million)

Figure 20. Europe Recombinant Human M-CSF Protein Sales Value by Country (%), 2024 VS 2031

Figure 21. Asia Pacific Recombinant Human M-CSF Protein Sales Value, (2020-2031) & (US$ Million)

Figure 22. Asia Pacific Recombinant Human M-CSF Protein Sales Value by Region (%), 2024 VS 2031

Figure 23. South America Recombinant Human M-CSF Protein Sales Value, (2020-2031) & (US$ Million)

Figure 24. South America Recombinant Human M-CSF Protein Sales Value by Country (%), 2024 VS 2031

Figure 25. Middle East & Africa Recombinant Human M-CSF Protein Sales Value, (2020-2031) & (US$ Million)

Figure 26. Middle East & Africa Recombinant Human M-CSF Protein Sales Value by Country (%), 2024 VS 2031

Figure 27. Key Countries/Regions Recombinant Human M-CSF Protein Sales Value (%), (2020-2031)

Figure 28. United States Recombinant Human M-CSF Protein Sales Value, (2020-2031) & (US$ Million)

Figure 29. United States Recombinant Human M-CSF Protein Sales Value by Type (%), 2024 VS 2031

Figure 30. United States Recombinant Human M-CSF Protein Sales Value by Application (%), 2024 VS 2031

Figure 31. Europe Recombinant Human M-CSF Protein Sales Value, (2020-2031) & (US$ Million)

Figure 32. Europe Recombinant Human M-CSF Protein Sales Value by Type (%), 2024 VS 2031

Figure 33. Europe Recombinant Human M-CSF Protein Sales Value by Application (%), 2024 VS 2031

Figure 34. China Recombinant Human M-CSF Protein Sales Value, (2020-2031) & (US$ Million)

Figure 35. China Recombinant Human M-CSF Protein Sales Value by Type (%), 2024 VS 2031

Figure 36. China Recombinant Human M-CSF Protein Sales Value by Application (%), 2024 VS 2031

Figure 37. Japan Recombinant Human M-CSF Protein Sales Value, (2020-2031) & (US$ Million)

Figure 38. Japan Recombinant Human M-CSF Protein Sales Value by Type (%), 2024 VS 2031

Figure 39. Japan Recombinant Human M-CSF Protein Sales Value by Application (%), 2024 VS 2031

Figure 40. South Korea Recombinant Human M-CSF Protein Sales Value, (2020-2031) & (US$ Million)

Figure 41. South Korea Recombinant Human M-CSF Protein Sales Value by Type (%), 2024 VS 2031

Figure 42. South Korea Recombinant Human M-CSF Protein Sales Value by Application (%), 2024 VS 2031

Figure 43. Southeast Asia Recombinant Human M-CSF Protein Sales Value, (2020-2031) & (US$ Million)

Figure 44. Southeast Asia Recombinant Human M-CSF Protein Sales Value by Type (%), 2024 VS 2031

Figure 45. Southeast Asia Recombinant Human M-CSF Protein Sales Value by Application (%), 2024 VS 2031

Figure 46. India Recombinant Human M-CSF Protein Sales Value, (2020-2031) & (US$ Million)

Figure 47. India Recombinant Human M-CSF Protein Sales Value by Type (%), 2024 VS 2031

Figure 48. India Recombinant Human M-CSF Protein Sales Value by Application (%), 2024 VS 2031

Figure 49. Recombinant Human M-CSF Protein Industrial Chain

Figure 50. Recombinant Human M-CSF Protein Manufacturing Cost Structure

Figure 51. Channels of Distribution (Direct Sales, and Distribution)

Figure 52. Bottom-up and Top-down Approaches for This Report

Figure 53. Data Triangulation

Figure 54. Key Executives Interviewed